Sustained Survival Benefit in Recurrent Medulloblastoma by a Metronomic Antiangiogenic Regimen: A Nonrandomized Controlled Trial.
Andreas Peyrl,Monika Chocholous,Magnus Sabel,Alvaro Lassaletta,Jaroslav Sterba,Pierre Leblond,Karsten Nysom,Ingrid Torsvik,Susan N Chi,Thomas Perwein,Neil Jones,Stefan Holm,Per Nyman,Helena Mörse,Anders Öberg,Liesa Weiler-Wichtl,Ulrike Leiss,Christine Haberler,Maresa T Schmook,Lisa Mayr,Karin Dieckmann,Marcel Kool,Johannes Gojo,Amedeo A Azizi,Nicolas André,Mark Kieran,Irene Slavc JAMA oncology(2023)
摘要
ClinicalTrials.gov Identifier: NCT01356290.
更多查看译文
AI 理解论文
溯源树
样例